Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects
Maarouf C, Beach T, Adler C, Shill H, Sabbagh M, Wu T, Walker D, Kokjohn T, Roher A, Consortium A. Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects. Neurological Research 2012, 34: 669-676. PMID: 22889670, PMCID: PMC3681206, DOI: 10.1179/1743132812y.0000000063.Peer-Reviewed Original ResearchConceptsParkinson's diseaseCerebrospinal fluidPostmortem ventricular cerebrospinal fluidCerebrospinal fluid biomarkersNormal control subjectsYears of ageVentricular cerebrospinal fluidPD patientsFluid biomarkersControl subjectsConsensus panelDefinitive biomarkersApolipoprotein EPD casesPD pathogenesisPotential biomarkersClinical diagnosisNeurodegenerative disordersApolipoprotein ADiseaseModifying treatmentsTwo-dimensional difference gel electrophoresisBiomarkersDiagnostic toolDifference gel electrophoresis